HopeStage
Back to all studies
Active Not RecruitingNCT06213324

Ketamine, brain activity, anxiety and loss of pleasure in depression

About this titleRead the official source — NCT06213324
Medication studyAges 18–65United States
The study in practice

Understand this study

Who could participate?

Listed age limits: 18 years to 65 years.

What will I do during this study?

Depending on the group, the protocol specifies the study medication (ketamine) or a placebo (an inactive comparison treatment).

Listed locations
New YorkSee all locations and recruitment
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: January 31, 2024
Recruitment status
Active Not Recruiting
Enrollment listed in the registry
120
Sponsor
Icahn School of Medicine at Mount Sinai
Sponsor type
University
Study type
Drug
Intervention type
Drug
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Locations
United States
Age range
From 18 Years to 65 Years
Official registry ID
NCT06213324
Official title
Show the full official title

Neural Circuit-Specific Mechanisms of Ketamine's Effect on Anhedonia and Anxiety in Depression Using Ultra-High Field 7-Tesla MRI

Recruitment & locations

Not recruiting

New York

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Icahn School of Medicine at Mount Sinai, a university.

Does this study involve medication?

Yes. The study involves medication, including ketamine and Placebo.

Who can participate?

Listed age limits: 18 years to 65 years.

Is this study still recruiting?

The registry lists this study as active, but no longer recruiting.

Want to explore more studies?

Explore studies